A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2021-02-09
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate the efficacy of enzalutamide in participants with
advanced hepatocellular carcinoma (HCC) as measured by overall survival (OS).
This study also evaluated the safety of enzalutamide; pharmacokinetics of enzalutamide and
the active metabolite N-desmethyl and Progression Free Survival (PFS) of enzalutamide as
compared to placebo in participants with advanced HCC.